Medtronic MDT Neuroscience — Other segment items
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's neuroscience — other segment items.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's neuroscience — other segment items?
- Medtronic (MDT) reported neuroscience — other segment items of $13M in Q1 2026.
- How has Medtronic's neuroscience — other segment items changed year-over-year?
- Medtronic's neuroscience — other segment items increased by 8.3% year-over-year, from $12M to $13M.
- What is the long-term trend for Medtronic's neuroscience — other segment items?
- Over 3 years (2023 to 2026), Medtronic's neuroscience — other segment items has grown at a -21.4% compound annual growth rate (CAGR), from $74M to $36M.
- What does neuroscience — other segment items mean?
- This category aggregates miscellaneous expenses or income items specific to the Neuroscience segment that do not fit into standard operating categories like R&D or SG&A. It provides transparency into non-recurring or unique segment-level financial activities.